As a dry eye specialist in a multispecialty practice, Dr. Roberto “Bobby” Saenz offers advice on comprehensive therapy, including treatment for flares.
Lumenis Receives FDA Approval for Its IPL Device to Manage Dry Eye Disease and Launches OptiLight™
Lumenis Ltd., the world’s largest energy-based medical device company for ophthalmic, aesthetic and surgical applications and the inventor of intense pulsed light (IPL) technology, today announced that the FDA has granted De Novo authorization for Lumenis’ newest IPL device for improving signs of dry eye disease due to meibomian gland dysfunction (MGD).
Fundamental Help for Patients: A 6-Month Look at Implementing Optima IPL
After just 6 months with Optima IPL, Carly Rose, OD is seeing incredible patient results, an increased demand in dry eye services, and a fast ROI on her investment.
Preview of the New Digital Duet/Trio, the First Digital SLT+YAG
Steven Dell, MD and Derek Cunningham, OD get a hands-on look at the improved digital capabilities of the newly released Digital Duet/Trio.
Stop the Drops: How SLT and IPL Improve Ocular Health and Quality of Life
Steven Vold, MD turns to two in-office solutions from Lumenis to reduce his patients’ dependence on drops and give them back control of their daily life.
6 Tips for Implementing Optima IPL in Your OD Practice
Make dry eye treatment a central focus of your OD practice with these tips for success from Jaime L. King, OD.
Telemedicine for Triage: Life-saving Now and Efficient in the Future
Adapting to the new normal during the pandemic, Douglas K. Devries, OD used telemedicine to his advantage to triage his dry eye patients, avoiding gaps in essential care.
COVID-19 Pandemic: Tips for Staying Connected with Dry Eye Patients
When COVID-19 forced a global shutdown, Bridgitte Shen Lee, OD planned ahead and developed creative ways to continue to serve her dry eye patients remotely.
SLT – Mechanism of Action
Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.
Optima IPL Receives CFDA Mark Approval for Treatment of Dry Eye Disease
Optima IPL Receives CFDA Mark Approval for Treatment of Dry Eye Disease
Now this exciting technology is available to practitioners in China for DED